News Focus
News Focus
icon url

postes

03/07/20 12:52 PM

#250675 RE: Whalatane #250672

I think the man for this job is not JT.
He has perhaps the best drug in decades and he if fumbling the ball.
I judge his abilities by the stock price..that is what I care about as an investor and shareholder.
icon url

dukesking

03/07/20 1:27 PM

#250677 RE: Whalatane #250672

Kiwi, well said. I agree. A win is first and foremost. Scripts may be affected by the current virus situation and market disruptions that are outside of JT’s control. It most likely will affect scripts and other growth metrics but AMRN can’t do much about that and they won’t be the only ones impacted. All AMRN can do is continue to execute the launch and continue educating/negotiating with formularies, pharmacies, and potential suitors as well as fine tune advertising and messaging. Got to get past judges decision first and we can worry about the rest later. After that, AMRN will either be bought or they’ll hit the advertising and educational blitz hard in Q2. IMO